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Creosote bush, Larrea tridentata (Sesse y Moc. Ex DC, Zygophyllaceae) is a shrub
found in the deserts of Northern Mexico and Southwestern United States. In traditional
medicine, it is used to treat a variety of illnesses including type 2 diabetes. The present
study aims to investigate the effects of creosote bush ethanolic extract on plasma and
liver parameters associated with the metabolic syndrome in hamsters fed a high fat and
cholesterol diet (HFD), comparing them with those induced by ezetimibe (EZ). Seven
groups of six hamsters each were formed. Six groups were fed HFD for 2 weeks. The
following 2 weeks, the HFD groups received: (1) only HFD, (2) HFD + 3 mg% EZ, (3)
HFD + 0.2% creosote bush ethanolic extract, (4) only standard diet (Std Diet), (5) Std
Diet + 3 mg% EZ, (6) Std Diet + 0.2% creosote bush ethanolic extract. The beneficial
effects of creosote bush ethanolic extract in the HFD hamster model were a reduction
of insulin resistance, associated with lower serum insulin and leptin, lower hepatic lipid
peroxidation and higher liver antioxidant capacity. Plasma and liver lipids tended or
were reduced to values closer to those of animals fed standard diet. A similar effect
on lipids was induced by EZ, although with even lower hepatic cholesterol and total
lipids concentrations. In general, the change from HFD to standard diet plus ethanolic
extract induced the same but deeper changes, including a reduction in plasma glucose
and an increase in the percentage of HDL cholesterol. Unlike creosote bush extract,
EZ increased food consumption and neutral fecal steroids, with no significant effect on
body weight, epididymal fat pads, liver peroxidation or antioxidant capacity. Also EZ
did not modify serum insulin and leptin. However, insulin sensitivity improved to values
similar to those induced by the extract. This suggests that the mechanism of action
of creosote bush ethanolic extract is different to inhibition of cholesterol absorption or
increase excretion. The ethanolic extract of L. tridentata could be useful in the treatment
of the metabolic syndrome.
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INTRODUCTION
Creosote bush, Larrea tridentata (Sesse y Moc. Ex DC,
Zygophyllaceae) is a shrub found in the deserts of Northern
Mexico and Southwestern United States. The resin that covers
the leaves contains flavonoid aglycones, as well as several
lignans, notably including the antioxidant NDGA (Konno et al.,
1990). Other lignans present are the linear ones, guaiaretic
acid and meso-dihydroguaiaretic acid, and the cyclolignans,
norisoguaiacin and it’s 3 methyl derivative (Gnabre et al., 2015).
L. tridentata contains about 0.1% of dry weight as volatile oils,
mainly monoterpenoids and aromatic sesquiterpenoids (Mabry
and Bohnstedt, 1981; Xue et al., 1988). The ethanol extraction
of leaves and twigs of L. tridentata, at room temperature, yields
10% resin in a dry weight basis, containing 26% NDGA (Belmares
et al., 1981).
Creosote bush is used to treat a variety of illnesses including
type 2 diabetes. Oral decoctions and extracts of leaves and twigs
have been used by the Pima Indians in the United States and
in Mexico for the treatment of diabetes (Winkelman, 1989).
Additionally, it has been reported that NDGA reduces plasma
glucose and TGs in rats treated with streptozotocin (Luo et al.,
1998; Reed et al., 1999); it also reduces TG secretion and liver
TG content in rats with fructose-induced hypertriglyceridemia
(Scribner et al., 2000) and inhibits dipeptidyl peptidase 4
(Roskar et al., 2016). Many of the pharmacological activities
of L. tridentata have been ascribed to its lignans, although
many other components are present in the extract that could
be synergizing or potentiating its activities. Thorough reviews
dealing with the medicinal uses and phytochemistry of creosote
bush and NDGA are available (Arteaga et al., 2005; Gnabre et al.,
2015).
A risk factor for developing type 2 diabetes and cardiovascular
disease, is the MS. Central obesity and insulin resistance are
acknowledged as important causative factors. According to the
IDF (Alberti et al., 2006), MS includes central obesity and two of
the following factors: decreased HDL cholesterol, elevated TGs,
high blood pressure and raised fasting glucose. Hyperleptinemia,
due to leptin resistance, may also be an important etiological
component of the MS (Wang et al., 2010). Persons with MS are
predispose to develop fatty liver and its complications (Wang
et al., 2010).
Since MS is a group of metabolic abnormalities that recently
have been characterized, it is difficult to find in the Mexican
traditional medicine plants specifically used for its treatment.
However, creosote bush is used to control hyperglycemia and
hyperlipidemia, two key factors of the MS (Winkelman, 1989).
The aim of the present work was to study the effects of creosote
bush ethanolic extract on the Syrian golden hamster fed a high
fat and cholesterol diet that expresses some components of the
MS, in order to determine its possible use in the treatment of
this alteration. Since change of life style, mainly diet and exercise,
is recommended for treatment of MS in humans, the effect
of changing high fat diet to maintenance diet with or without
Abbreviation: HFD, high fat diet; IDF, International Diabetes Federation; MS,
metabolic syndrome; NDGA, nordihydroguaiaretic acid; TG, triglycerides.
creosote bush ethanolic extract was tested. It was expected that
the change of diet plus extract could induce higher improvement
of the altered parameters.
MATERIALS AND METHODS
Plant Extract
The plants of L. tridentata used to prepare the ethanolic
extract were collected at San Luis Potosi State, Mexico. Voucher
specimens were deposited at the National Herbarium, Institute
of Biology, UNAM (MEXU; no. 534807) and at the Herbarium of
Medicinal Plants, S. XXI Medical Center (IMSS; nos 11 319–11
321).
The ethanolic extract was prepared from 100 g of coarsely
fragmented leaves and twigs, extracted in 1 L absolute ethanol,
mixed for 30 min at room temperature, filtered with paper
and reduced to approximately 40 mL in a rotary evaporator
under reduced pressure and then lyophilized. The ratio of the
herbal drug to the herbal drug preparation (DER native) was
10:1.
NDGA Content in the Ethanolic Extract
For the HPLC analysis, an Agilent 1260 Infinity system
with diode array detector and a Macherey–Nagel 100-5 C18
(250 mm× 4.6 mm) column were employed, with H3PO4 0.04 M
and acetonitrile (ACN) mixtures as mobile phase, at a flow rate of
1.5 ml/min and 20 µl sample volume injection. Initially a relation
of H3PO4/ACN 70:30 (v/v) was started, with ACN concentration
being increased up to 50% by minute 15. Then ACN was
increased again, so that a relation of H3PO4/ACN 30:70 (v/v) was
reached by minute 19. Finally, mobile phase was returned to an
ACN proportion of 30% by minute 21. NDGA (Sigma–Aldrich)
and creosote bush ethanolic extract were dissolved in methanol.
An NDGA standard curve was made in the range 20–80 µg/ml,
following absorbance at 280 nm. As shown in the chromatogram
(Figure 1), the creosote bush extract contains NDGA (8.9%),
together with several other peaks, which could be O-methylated
derivatives that have been reported in creosote bush (Gnabre
et al., 2015).
Animals and Diets
Thirty-six male Syrian hamsters, 5-week-old, weighing 72 g were
obtained from the stock colony kept at the animal house from
the Faculty of Sciences, UNAM, Mexico, were fed ad libitum
with a HFD containing standard rodent chow (Std diet: Purina
Nutricubes; 3.39 kcal/g) 70%, casein 6.9%, cellulose 1.5%, lard
20%, methionine 0.12%, choline 0.042%, AIN-93M Mineral Mix
1.05%, AIN-93Vitamin Mix 0.3% and cholesterol 0.1%. The
energy content was 4.46 kcal/g diet. The control group (n = 6)
was fed with the standard rodent chow. After 2 weeks, the
hamsters on HFD were randomly divided in six groups of six
animals each with average similar body weight and fed the
following diets and water ad libitum: (1) HFD; (2) HFD with
added ezetimibe (EZ; Zient, Schering-Plough) at 3 mg% as a
positive control; (3) HFD added with creosote bush ethanolic
extract at 0.2%; (4) standard rodent chow (Std diet); (5) Std diet
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FIGURE 1 | HPLC chromatogram of creosote bush extract.
added with creosote bush ethanolic extract at 0.2%, and (6) Std
diet with 3 mg% EZ. The level of extract included in the HFD diet
was based upon the result of a preliminary experiment indicating
a higher and more consistent effect on plasmatic lipids than with a
lower one (0.1%). A higher level (0.25%) was equally effective. EZ
was chosen as a positive control at 3 mg% of diet (∼2 mg/kg b.w.),
since it had been reported that this dose is effective in normalizing
the combined dyslipidemia induced by high fat diet in male
hamsters (van Heek et al., 2001). Each group was housed in a
stainless steel cage with sawdust bedding, at 22 ± 2◦C, under a
14:10 h light–dark cycle. Food consumption was measured every
other day.
The animals were handled according to the Health Guide for
the Care and Use of Laboratory Animals (Office of animal care
and use of the National Institute of Health, 1996). All methods
used in this study were approved by the Internal Council of the
Facultad de Ciencias of the Universidad Nacional Autónoma de
México.
Blood and Tissues Sample Collection
At the end of the fourth week the animals were fasted for
4 h, anesthetized with pentobarbital (50 mg/kg b.w. i.p.) and
blood samples were taken from the retro-orbital sinus with
heparinized and non-heparinized capillary tubes. An insulin
tolerance test was then performed as shown below. After the
insulin tolerance test, the animals were euthanized with a
pentobarbital overdose. The liver and epididymal fat depots were
dissected, weighed and frozen at −40◦C. Plasma and serum was
obtained by centrifugation on a hematocrit centrifuge and kept
at−40◦C.
Plasma and Serum Analysis
Plasma glucose, TGs, total cholesterol, and HDL cholesterol were
determined with enzymatic-colorimetric assay kits (SpinReact,
Girona, Spain). Insulin and leptin serum concentrations were
determined by ELISA Kits (Millipore Rat/Mouse Insulin, Rat
Leptin).
Insulin Tolerance Test
Under anesthesia the insulin tolerance test (ITT) was performed
with an insulin injection (i.p.) at a dose of 0.2 IU/100 g
body weight, blood from the retro-orbital sinus was sampled
at 0, 5, 10, and 15 min after insulin injection. Plasma glucose
was determined with an enzymatic-colorimetric assay kit, as
above.
Liver Parameters
A liver sample was homogenized in a Dunce apparatus with
methanol:chloroform (1:1) and centrifuged at 1000× g for 5 min
at 4◦C. Supernatant samples were evaporated under vacuum and
total lipids measured by the phospho-vanillin method (Inouye
and Lotufo, 2006), TGs and cholesterol by enzymatic colorimetric
assays (SpinReact, Girona, Spain).
A 10% liver homogenate in saline was prepared and
centrifuged at 1000 × g for 10 min at 4◦C. Liver peroxidation
was determined by Thiobarbituric Acid Reactive Substances
method (TBARs; Ohkawa et al., 1979) and antioxidant capacity
by DPPH assay (Hsu et al., 2007; Sharma and Bhat, 2009) in the
homogenate supernatant.
Neutral Fecal Sterols
The neutral fecal sterols were extracted with
chloroform:methanol:saline (2:1:0.75) from samples of 72 h
feces collected at the end of the second week of treatments.
Feces were dried, powdered and homogenized. Sterols were
determined in the dried organic phase by the Lieberman–
Burchard reaction (Richterich and Colombo, 1981), with
cholesterol as standard.
Statistical Analyses
Statistical analyses and graphics were performed with GraphPad
Prism version 6.00 for Windows (GraphPad Software, La Jolla,
CA, USA). All data are reported as mean ± SD for the
specified number of samples. Differences between mean values
were tested for statistical significance (P < 0.05) by 1-way
ANOVA. Tukey HSD was used as post hoc test. Pearson
correlation was performed between body weight and epididymal
fat depots.
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RESULTS
Body Weight, Epididymal Fat Depots,
and Food Consumption
After the first 2 weeks on HFD, six groups of similar body weight
were formed. Although these groups had higher body weight, it
was not significantly different from that of the Std diet fed group
(Table 1). After 4 weeks, significant (P < 0.05) differences in
body weight among groups were found. Animals on HFD were
significantly heavier than those on Std diet. Groups with EZ,
creosote bush ethanolic extract and those changed from HFD to
Std diet with or without EZ were not significantly different from
the heaviest HDF group nor from the lighter one that receiving
only Std diet for 4 weeks. The group changed from HFD to Std
diet with extract exhibited a significantly (P < 0.05) lower body
weight than that of the HFD group and very similar to the one
fed Std diet for 4 weeks. Epididymal fat depots followed the same
pattern, except that the lighter group was the one that changed to
Std diet added with extract. A significant correlation was found
between body weight and epididymal fat weight (r = 0.8, n= 42,
P < 0.001).
In relation to food consumption, there were significant
differences among groups. The lowest food consumption among
the groups with HFD for the last 2 weeks was the one with HFD
and L. tridentata extract, but consumption was not significantly
different from the groups fed either HFD or Std diet for
4 weeks. The change from HFD to Std diet did not differ in
food consumption from those with Std for 4 weeks nor the
one with HFD. The change to Std diet plus extract induced a
significantly higher consumption than the change to Std diet
without additions. The group that changed from HFD to Std diet
and EZ exhibited the significantly highest food consumption of
all groups (P < 0.05).
Plasma Parameters
At the end of the treatment period, there were significant
differences in plasma parameters among groups (Figure 2).
Glucose was not significantly different among groups fed only Std
diet or HFD with or without any addition. Also, no differences
were found among the three groups changed to Std diet.
However, addition of EZ or creosote bush extract induced lower
glucose concentrations in the groups changed to Std diet when
compared with Std diet and HFD controls (P < 0.05).
In TGs, no significant difference was found between Std diet
and HFD control groups. The addition of EZ and extract to
HFD lower this parameter (P < 0.05). The change to Std diet
with or without additions did not significantly altered TGs. Total
cholesterol was higher in HFD control group (P < 0.05). Both
EZ and extract additions to HFD induced lower concentration
than those of the HFD and Std diet controls. The change to Std
diet return cholesterol level to Std diet control concentrations.
Creosote bush extract in the Std diet significantly reduced
cholesterol, whereas EZ addition did not when were compared
with the group on HFD changed to Std diet.
In relation to HDL cholesterol, groups with HFD, except the
one with EZ, exhibited higher values than the Std diet control
group. The change to Std diet reduced HDL cholesterol to values
significantly (P < 0.05) different from the HFD control group.
Addition of EZ or extract to the Std diet had no effect on HDL
cholesterol, when compared with the group that change to Std
diet.
Serum Insulin and Leptin
As shown in Figure 3, there were increments in both insulin and
leptin serum concentrations in groups fed with HFD and HFD
plus EZ. Added to HFD, the ethanolic extract reduced leptin and
insulin to values significantly (P < 0.05) different from those
obtained with HFD.
The change from HFD to Std diet reduced leptin but
not insulin concentration. Addition of EZ did not induce a
significant reduction of any of the two hormones from the
concentrations found in the HFD group. The change to Std diet
added with ethanolic extract induced the lowest levels of leptin
and insulin of all groups, although they were not significantly
different from those found in the group with Std diet for
4 weeks.
Insulin Tolerance Test
There were significant differences in the sensitivity to an insulin
injection, expressed as the percentage reduction of the initial
glucose concentration per minute (Table 2). The HFD group
showed the lowest sensitivity to insulin. The additions of
ethanolic extract of creosote bush or EZ to the HFD induced
TABLE 1 | Body weight and food consumption in hamsters∗.




Epididymal fat pads (g) Food consumption
(g/animal/day)1
Std. diet (4 weeks) 97,2 ± 7,2a 111,3 ± 9,7a 1,43 ± 0,29a,c 7,9 ± 1.0a,b
HFD (4 weeks) 109,8 ± 10,5a 133,5 ± 10,5b 1,90 ± 0,28b 8,5 ± 0.3a,b,d
HFD + 3mg% ezetimibe 109,2 ± 7,4a 126,5 ± 11,0a,b 1,88 ± 0,25a,b 9,2 ± 0.5a,d
HFD + 0.2% ethanolic extract 109,0 ± 8,9a 119,7 ± 10,4a,b 1,43 ± 0,18a,c 6,8 ± 0.8b
HFD→Std. diet 108,8 ± 6,0a 120,2 ± 5,5a,b 1,50 ± 0,18a,b,c 7,9 ± 0.4a,b
HDF→Std. diet + 3 mg% ezetimibe 108,8 ± 10,8a 125,0 ± 14,0a,b 1,67 ± 0,35a,b 14,1 ± 2.2c
HFD→Std. diet + 0.2% ethanolic extract 108,8 ± 11,3a 112,2 ± 10,5a 1,06 ± 0,22c 9,8 ± 1,6d
∗Mean ± SD, n = 6 per group. Different letter in the same column indicate a statistical difference (P < 0.05; ANOVA and Tukey).
1Food consumption on last 2 weeks, n = 8 per group.
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FIGURE 2 | Plasma (A) glucose, (B) triglycerides, (C) cholesterol, and (D) HDL cholesterol in hamsters fed HFD for 2 weeks and Std diet or HFD diet
with or without creosote bush extract or ezetimibe (EZ) for another 2 weeks. Mean ± SD, n = 6 per group. Different letter between columns means
significant difference (P < 0.05).
FIGURE 3 | Serum insulin (A) and leptin (B) concentrations in hamsters fed HFD for 2 weeks and Std diet or HFD diet with or without creosote bush
extract or EZ for another 2 weeks. Mean ± SD, n = 6 per group. Different letter between columns means significant difference (P < 0.05).
significant (P < 0.05) increases in insulin sensitivity, which were
not different from the group fed Std diet. The change from HFD
to Std diet similarly increased the sensitivity to insulin to an
intermediate value that was not different from that of the control
group receiving Std diet for 4 weeks. The change from HFD to
Std diet added with EZ further increased sensitivity to a value
not significantly different from either the control group fed Std
diet for 4 weeks or the group changed to Std diet. The highest
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TABLE 2 | Insulin tolerance test in hamsters fed HFD and experimental
diets.
Groups and diets % Glucose decrease/min∗
Std. diet (4 weeks) 4,58 ± 2,19a,c
HFD (4 weeks) 0,65 ± 1,82b
HFD + 3 mg% Ezetimibe 2,46 ± 0,41a,d
HFD + 0.2% ethanolic extract 2,09 ± 0,96a,e
HFD→Std. diet 2,55 ± 1,02a,f
HDF→Std. diet + 3 mg% Ezetimibe 3,86 ± 0,76c,d,e,f
HFD→Std. diet + 0.2% ethanolic extract 5,96 ± 0,66c
∗Mean ± SD, n = 4 per group. Different letter means significant difference
(P < 0.05).
sensitivity to insulin was induced by the change from HFD to Std
diet added with ethanolic extract, to a value different from that of
the group changed to Std diet (P < 0.05).
Liver Weight and Lipids
In relation to liver weight (Figure 4A), the group with HFD
showed the highest values in absolute and percent liver weight,
being different from the group with only Std diet (P < 0.05). The
addition of EZ to HFD reduced liver weight to control values
(P < 0.05). Liver weight from animals on HFD and creosote
bush extract were lower, but did not significantly differ from the
ones on HFD. The change from HFD to Std diet for 2 weeks
did not significantly reduced liver weight. However, addition of
EZ or extract returned liver weight to control values (Std diet
group).
Total lipids (Figure 4B) were highest in the group on HFD.
EZ decreased (P < 0.05) this parameter to control levels, whereas
extract, although significantly reduced total lipids, did not reach
control values. The change from HFD to Std diet also decrease
total lipids to levels that did not significantly differ from control
levels. Addition of EZ or extract to Std diet, although showed
lower total lipids, were not significantly different from only Std
diet. With cholesterol (Figure 4C) similar changes occurred,
i.e., HFD induced higher concentration that were lowered by
EZ, but the extract did not reach a significant difference with
the HFD group. The change to Std diet without additions
significantly reduced liver cholesterol concentrations, but none
of the two additions made a significant difference from control.
Hepatic TGs (Figure 4D) were higher with HFD and with
HFD and EZ, respect to Std diet. Extract addition induced TG
levels that also were not different from those with only HFD,
however, values were neither significantly different from those
in the group with only Std diet. The change to Std diet with
or without addition returned TG levels to control (Std diet)
concentrations.
Liver Peroxidation and Antioxidant
Capacity
As seen in Figure 5, unexpectedly, TBARS were twice as
high in the control group than in the HFD one (P < 0.05).
The group with HFD added with EZ, although with higher
concentrations, did not statistically differ from the one on
HFD. The addition of extract induced the lowest concentrations,
although not significantly different from those in the HFD
group. The change to Std diet induce again high TBARS to
levels similar to Std diet for 4 weeks. Addition of EZ did not
reduced TBARS, whereas extract addition significantly lowered
this parameter.
Antioxidant capacity measured as delayed oxidation of DPPH,
was not significantly different in control, HFD and HFD with
EZ groups, only the one with addition of extract statistically
(P < 0.05) increased the liver antioxidant capacity. The change to
Std diet showed high values of antioxidant capacity that were not
modified by EZ or extract additions, but neither were statistically
different from control nor HFD values.
Neutral Fecal Sterols
As shown in Figure 6, there was a significant (P < 0.05) increase
in neutral fecal sterols in the groups with EZ, when compare with
their own controls (HFD and HFD→Std diet groups). In the
groups that received extract, fecal sterols were not significantly
different from their own controls, which indicates that the extract
effect is not related to a reduction of intestinal cholesterol
absorption or increased excretion.
DISCUSSION
The Syrian golden hamster (Mesocricetus auratus) has a
cholesterol and lipoprotein metabolism similar to that of humans
(Bravo et al., 1994). This characteristic makes it an excellent
model for studies on dyslipidemia and hypercholesterolemia,
because changes in plasma lipids can be induced by specific
dietary formulations, like the high fat and cholesterol diet (van
Heek et al., 2001; Valasek et al., 2008; Zhang Z. et al., 2009). The
present study also shows that a diet based on lard and cholesterol
is effective in inducing some of the MS parameters, such as
increased body weight, high plasma and hepatic lipids and low
sensitivity to insulin. In general, the addition of creosote bush
ethanolic extract to the HFD decreases plasma and hepatic lipids,
increases the sensitivity to insulin and normalizes plasma insulin
and leptin levels.
In humans, prevalence of MS is slightly higher in women than
in men (Marquez-Sandoval et al., 2011; Beigh and Jain, 2012;
Beltran-Sanchez et al., 2013). In the present study, only males
were used, since the response to high fat diet is more pronounced
in males than in females, with higher plasma total cholesterol and
TG (Morise et al., 2006). In another study, hamsters of different
sex and age were fed a high-calorie diet, dyslipidemia developed
in males, irrespective of age, whereas in females only developed
with aging (Zagayko et al., 2015). Nonetheless, it remains to
be established whether the extract of L. tridentata has the same
effects in females as in males.
Since the treatment of type 2 diabetes and MS in humans
usually involves diet, exercise, and pharmacological therapy, in
the present study the further effect of creosote bush extract on
the change to a less caloric diet, such as maintenance diet, was
analyzed. Several parameters, such as body weight, epididymal
fat depots, plasma cholesterol, insulin, leptin, sensitivity to
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FIGURE 4 | Liver weight and liver lipids concentration in hamsters fed HFD for 2 weeks and Std diet or HFD diet with or without creosote bush
extract or EZ for another 2 weeks. (A) Liver weight, (B) total lipids, (C) cholesterol, and (D) triglycerides. Mean ± SD, n = 6 per group. Different letter between
columns means significant difference (P < 0.05).
FIGURE 5 | Liver peroxidation (A) and antioxidant capacity (B) in hamsters fed HFD for 2 weeks and Std diet or HFD diet with or without creosote
bush extract or EZ for another 2 weeks. Mean ± SD, n = 6 per group. Different letter between columns means significant difference (P < 0.05).
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FIGURE 6 | Neutral fecal sterols in hamsters fed HFD for 2 weeks and
Std diet or HFD diet with or without creosote bush extract or EZ for
another 2 weeks. Mean ± SD of three samples from pool of 48 h feces.
Different letter between columns means significant difference (P < 0.05).
insulin, percent liver weight and peroxidation exhibited a further
significant improvement with the change of diet and the addition
of extract, in a 2 weeks treatment period, than with only a change
to a less caloric diet, as the Std diet.
After 2 weeks of treatments, food consumption was similar
among groups. The exception was the one fed Std diet with EZ,
that exhibited the highest consumption of all, but despite that,
it showed a body weight similar to that of the HFD animals.
The epididymal fat pads, which reflect body adiposity, increased
in hamsters fed HFD. EZ had no effect in this parameter, as
previously published in hamsters (van Heek et al., 2001). The
addition of creosote bush ethanolic extract to the HFD or to
the Std Diet, induced the lowest body weight and adiposity
of all groups, but not significantly different from the control
group with Std diet for 4 weeks. The creosote bush ethanolic
extract could have reduced nutrient absorption or accelerated the
metabolism, since these groups gained less weight despite similar
food consumption. In the short term this seems a beneficial
effect, however, in the long term these could be a toxic one,
also considering that excessive use of creosote bush can lead to
hepatic and renal toxicity (Gordon et al., 1995; Sheikh et al.,
1997).
Both EZ and creosote bush extract reduce plasma TGs and
cholesterol, when added to the HFD. This shows a beneficial
effect of the extract on components of the MS. A similar result
on TGs was reported to be induced by Masoprocol (NDGA) in
streptozotocin treated diabetic rats (Reed et al., 1999). EZ has
previously been reported to reduce both parameters in hamsters
on a high fat and cholesterol diet (van Heek et al., 2001; Valasek
et al., 2008). HDL cholesterol was reduced by EZ in the HFD,
as reported by van Heek et al. (2001), but not by the extract.
The change to Std diet with or without additions, also decreases
cholesterol, particularly with extract addition. In relation to TGs,
the change to Std diet had no effect, and EZ or extract did
not reduce this parameter significantly. The differential effect of
extract and EZ when added to HFD and Std diet after HFD, may
be due to differences in the type of lipids between diets, rather
than in the quantity, since the fat content of the Std diet was 3.4%,
according to a proximal chemical analysis. Whatever the reason,
the Std diet used induced a high TG concentration.
Other characteristics of the MS are hyperinsulinemia,
hyperleptinemia, and insulin resistance. These three parameters
were present in the hamsters fed the HFD. The main
physiological cause for leptin hypersecretion is diet-induced
expansion of adipocytes. Circulating leptin levels are directly
proportional to the amount of body energy stores. As energy
storage capacity in adipocytes is exceeded during the period
between the onset of overweight/obesity and the start of the MS,
leptin resistance develops (Moon et al., 2013). This lack of action
leads to overfeeding and generalized steatosis and lipotoxicity
that leads to insulin resistance (Unger et al., 2010). The creosote
bush ethanolic extract added to the HFD decreased serum leptin
and insulin to normal values and insulin sensitivity to levels not
different from animals with Std diet. The change from HFD to
Std diet did not affect serum insulin, but leptin was reduced.
The addition of extract to Std diet decreases both hormones to
normal levels, as when added to the HFD. These effects could
be related to lower weight gain and lower adiposity, as shown
by low epididymal fat pads in both groups with extract, but not
due to lower food consumption. Several phenolic compounds,
such as resveratrol, oleuropein, and myricetin, as well as some
precursors or derivatives of phenols, such as polydatin, have
been found to reduce the level of circulating leptin in a
large range of in vivo studies, using different types of models
(Aragonés et al., 2016). In addition to phenolic compounds, other
plant secondary metabolites, such as isothiocyanates and some
terpenoids including thymol, saponins, and lycopenes among
others, have also been shown to be effective in reducing leptin
levels when administered to rodents (Aragonés et al., 2016).
The mechanisms of action of these compounds have not been
established for the majority of them. Resveratrol increases AMPK
activity, reducing lipogenesis and increasing lipid oxidation
(Zhang B.B. et al., 2009). Others, like some coumarins, flavonoids
and polyphenols from fruit juices, could act as PPAR agonists or
even improve leptin transport through the brain blood barrier
(Aragonés et al., 2016), enhancing the oxidation of surplus
fatty acids and reducing lipotoxicity (Unger et al., 2010). It
remains to be established how creosote bush extract, probably
through NDGA, reduces leptin resistance and improves insulin
sensitivity. EZ had no significant effect in leptin and insulin, as
reported by van Heek et al. (2001), although insulin sensitivity
did improve.
The HFD increased liver size and lipids as previously
published (van Heek et al., 2001; Valasek et al., 2008). In our
study, liver weight and lipids did not significantly decrease in
hamsters fed HFD added with creosote bush ethanolic extract,
except for total lipids. However, lower values were observed
in TGs and cholesterol, with hepatic TGs concentration not
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different from the level in animals on Std diet. Zhang et al.
(2015) reported a decrease in hepatic TGs with NDGA, the main
metabolite of creosote bush, in rats with a high fructose diet. EZ at
the level used was more effective in decreasing liver weight, total
lipids and cholesterol, a result that agrees with previous reports in
hamster (van Heek et al., 2001; Valasek et al., 2008). The change
from HFD to Std diet, with or without added EZ or extract, was
enough to return liver parameters to control values, although the
lowest values were those with the addition of extract or EZ.
Oxidative stress has been implicated in the development of
MS and type 2 diabetes (Hopps et al., 2010). Since the main
metabolite of the extract is NDGA, a recognized antioxidant,
peroxidation and antioxidant capacity in the liver were analyzed.
Liver peroxidation, estimated as TBARS, was higher with the Std
diet than with the HFD, while antioxidant capacity was similar
with both diets. This TBARS reduction with the HFD may be due
to differences in type of lipids between diets. In mice fed a diet
with 8% fish oil, which contains highly unsaturated fatty acids, a
significantly higher hepatic concentrations of TBARS was found
than with 10% lard (Ibrahim et al., 1997). This indicates that in
the HFD fed hamster, oxidative stress, at least in the liver, is not
associated with signs of the MS.
As expected, creosote bush ethanolic extract decreased
peroxidation with HFD and with the change to Std diet, and
increased antioxidant capacity with HFD. EZ had no effect on
these parameters, and it is known that its mechanism of action is
through inhibiting cholesterol absorption (van Heek et al., 2001;
Valasek et al., 2008). According to this, neutral fecal sterols were
increased by EZ in the present work. Creosote bush ethanolic
extract has been reported to have antibiotic actions (Mabry
et al., 1979; Argueta, 1994), which could have modified intestinal
microbiota. However, it does not affect cholesterol absorption as
indicated by neutral fecal sterols.
At least one active principle of creosote bush ethanolic
extract must be NDGA, which in the present study was found
to constitute 8.9% of our ethanolic extract. Belmares et al.
(1981) have reported that NDGA was 26% of ethanol extract
of leaves and twigs. The difference with our analysis may be
due to the methodology used. Belmares group employed gas
chromatography of trimethylsilyl derivatives, so that besides
NDGA, also several O-methylated derivatives, such as guaiaretic
acid, present in the extract were accounted for as NDGA.
Components of the extract include other lignans and flavonoids
(Timmermann, 1981; Vázquez-Yanes et al., 1999; Gnabre et al.,
2015). During many years, the beneficial effects of flavonoids
on health were ascribed to their antioxidant capacity. They can
also improve dyslipidemia by modulating lipid absorption and
lipogenesis (Galleano et al., 2012). It remains to be established
whether the “agua de uso” from creosote bush traditionally used
in diabetes treatment exerts the same effects as the ethanolic
extract. Our results and those of Zhang et al. (2015) with fructose
fed rats and NDGA, suggest that creosote bush derivatives also
have potential utility in the treatment of MS.
CONCLUSION
The beneficial effects of creosote bush ethanolic extract in the
HFD hamster model that develops some signs of the MS are
to reduce plasma TGs, total cholesterol, insulin and leptin, and
improve insulin sensitivity. These effects are associated with a
lower lipid peroxidation and an increase in antioxidant capacity
in the liver. When the HFD diet is changed to Std diet, plasma
glucose and cholesterol, serum leptin, insulin sensitivity and liver
lipids improve. The addition of creosote bush ethanolic extract to
Std diet, further reduces body and epididymal fat pads weight,
plasma glucose and cholesterol, serum insulin and leptin, liver
weight and peroxidation, also increasing sensitivity to insulin.
This suggests that the ethanolic extract of L. tridentata could be
useful in the treatment of the MS.
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